Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
Sign Up to like & getrecommendations! Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-59711-y
Abstract: The vaccine elicitation of broadly neutralizing antibodies against HIV-1 is a long-sought goal. We previously reported the amino-terminal eight residues of the HIV-1-fusion peptide (FP8) – when conjugated to the carrier protein, keyhole limpet hemocyanin… read more here.
Keywords: vaccine immunogen; preclinical development; fusion peptide; carrier ... See more keywords